Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability? by J. Humberto Rodriguez-Quintero, MD, MPH, Rajika Jindani, MD, MPH, MS, Roger Zhu, MD, Isaac Loh, Mohamed K. Kamel, MD, Anne Montal, MD, Marc Vimolratana, MD, MS, Neel P. Chudgar, MD, Nitin Ohri, MD, MS, Balazs Halmos, MD, MS, Brendon M. Stiles, MD

Get full text

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy by Julie M. Jiang, MD, PhD, Jeremy Eichler, MS, William Bodner, MD, Jana Fox, MD, Madhur Garg, MD, MBA, Rafi Kabarriti, MD, Allen Mo, MD, PhD, Shalom Kalnicki, MD, Keyur Mehta, MD, Amanda Rivera, MD, Justin Tang, MD, Johnny Yap, MD, Nitin Ohri, MD, Jonathan Klein, MD

Get full text

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry by Jacob Eckstein, MD, J. Isabelle Choi, MD, Alicia Lozano, MS, Nitin Ohri, MD, Robert Press, MD, Shaakir Hasan, DO, Rafi Kabarriti, MD, John Chang, MD, James Urbanic, MD, Michael Durci, MD, Nasiruddin Mohammed, MD, Craig Stevens, MD, PhD, Henry Tsai, MD, Smith Apisarnthanarax, MD, William Regine, MD, Carlos Vargas, MD, Romaine Nichols, Jr, MD, Joseph Herman, MD, Charles B. Simone, II, MD, Arpit Chhabra, MD

Get full text